Award recordCONTRACT

PROGENICS PHARMACEUTICALS INC

PIID 36C26122N0718· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6850 · MISCELLANEOUS CHEMICAL SPECIALTIES· FY2022· $52,704 net obligations· UEI YLYKVRPCTCR3· NY

Description

PYLARIFY

First action · last action
2022-09-07 · 2023-05-22
Transactions
3
First transaction's obligation
$105,407
Base + all options value (sum of deltas)
$52,704
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0170
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$105,407$0Base award · 2022-09-07 · this action $105,407 · running total $105,407Modification P00001 · 2022-09-07 · this action $0 · running total $105,407Modification P00002 · 2023-05-22 · this action -$52,704 · running total $52,704
  • Base2022-09-07+$105,407= $105,407
  • Mod P000012022-09-07+$0= $105,407
  • Mod P000022023-05-22-$52,704= $52,704
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-09-07+$105,407$105,407PYLARIFY
Mod P00001· OTHER ADMINISTRATIVE ACTION2022-09-07+$0$105,407PYLARIFY
Mod P00002· FUNDING ONLY ACTION2023-05-22−$52,704$52,704PYLARIFY

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI YLYKVRPCTCR3)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0890246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$1,212,530FY2026
36C24626A0027246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26226F0313262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$180,436FY2026
36C25026N0655250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$721,744FY2026
36C26026F0298260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$469,134FY2026
36C25026N0531250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$559,352FY2026

Other recipients under 6850 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126F0105INO THERAPEUTICS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$28,784FY2026
36C26124P0247ALTA MEDICAL SPECIALTIES LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$16,380FY2024
36C26122N0134RCG OF NORTH CAROLINA, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$53,152FY2022
36C26121P0212AIRGAS USA LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$551,530FY2021
36C26119N0620RCG OF NORTH CAROLINA, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$104,906FY2019

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26122N0718_3600_36F79719D0170_3600 · retrieved 2026-09-26.